Belfast-based AMPLY Discovery raises €1.6 million to tackle complex diseases with drug discovery platform

Published on February 12, 2024

Belfast-based techbio company AMPLY Discovery announced that it has raised over €1.6 million in grant funding from Innovate UK to develop new drug products using its proprietary AI-driven drug discovery platform. AMPLY’s existing investors include Co-fund NI, which is managed by Clarendon Fund Managers and supported by Invest NI and the British Business Bank, QUBIS…

This content is for members only. Visit the site and log in/register to read.

The post Belfast-based AMPLY Discovery raises €1.6 million to tackle complex diseases with drug discovery platform appeared first on EU-Startups.